跳至主要内容
临床试验/NL-OMON40569
NL-OMON40569已完成不适用

Remifentanil use for procedural sedation and analgesia in the emergency department - Remifentanil use for PSA in the emergency department

Albert Schweitzer Ziekenhuis0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • All the patients who need procedural sedation and analgesia at the emergency department or the observatorium of the Albert Schweitzer hospital location Dordwijk in Dordrecht, age 18 years and older, classified as ASA I en II.

排除标准

  • Age under 18 years, hemodynamic and/or respiratory instable, classified as ASA III, IV and V, suspicion of elevated intra-cranial pressure, pregnancy, use of opiates at home, opiates administered before PSA procedure started (in the ambulance, on arrival at the emergency department), intoxication, known allergy for fentanyl propofol remifentanil soy or chicken proteins

研究者

相似试验

Remifentanil use for procedural sedation and... | 临床试验